![](/img/cover-not-exists.png)
P2.16-41 Pembrolizumab for Previously Treated, PD-L1–Expressing Advanced NSCLC: Real-World Time on Treatment and Overall Survival
Velcheti, V., Chandwani, S., Chen, X., Piperdi, B., Burke, T.Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.1908
Date:
October, 2019
File:
PDF, 228 KB
2019